Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab-Reference-Cited by-同舟云学术

Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab

Published:2013-11-29 Issue:2 Volume:74 Page:415-421
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Listing Joachim,Kekow Jörn,Manger Bernhard,Burmester Gerd-Rüdiger,Pattloch Dagmar,Zink Angela,Strangfeld Anja

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference32 articles.

1. Length of life and cause of death in rheumatoid arthritis;Cobb;N Engl J Med,1953

2. The mortality of rheumatoid arthritis;Wolfe;Arthritis Rheum,1994

3. Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964–95;Bjornadal;J Rheumatol,2002

4. The widening mortality gap between rheumatoid arthritis patients and the general population;Gonzalez;Arthritis Rheum,2007

5. Associations of disease activity and treatments with mortality in men with rheumatoid arthritis: results from the VARA registry;Mikuls;Rheumatology (Oxford),2011

Cited by 223 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Survival on First Biologic Therapy Among Late‐Onset Rheumatoid Arthritis Patients Compared to Early‐Onset Patients: A Population‐Based Cohort Study;Musculoskeletal Care;2024-08-16

2. Survival in patients with rheumatoid arthritis and early breast cancer treated with tumor necrosis factor inhibitors;Breast Cancer;2024-08-08

3. Extensive study of CCN4, VCAM-1, MMP-3, and GM-CSF as reliable markers for disease activity in rheumatoid arthritis;Journal of Taibah University Medical Sciences;2024-08

4. Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA study;RMD Open;2024-06

5. European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency;The Journal of Clinical Endocrinology & Metabolism;2024-05-10